Leerink Partners senior managing director David Risinger (Cellarity)
‘This is self-inflicted’: Leerink’s David Risinger on the market shock and hits to biopharma
As the markets continued to fall Monday in response to the Trump administration’s tariff proposals, biotech has particularly been hit hard. The …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
